超1/3大额并购配置CVR,对赌因何活跃?

研发客
Feb 04

//• 并购交易总额翻倍增长,且采用CVR、Spin-Merge等更精准的交易结构;• 神经和代谢领域已超过肿瘤,成为收购方重点发掘的核心赛道;• 去年并购拥有商业化产品的公司占比提高到25%。2025年生物医药领域的并购(M&A)交易在2025年第四季度迎来高光收官——以32笔的交易量创下近四年来单季度交易数量的最高纪录。从全年整体表现看,2025年并购数量与2024年基本持平,但交易总额实现了...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10